[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100626762":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":46,"centralContacts":51,"locations":62,"responsibleParty":80,"collaborators":82,"id":85,"slug":86,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":56,"eligibilityCriteria":91,"healthyVolunteers":87,"sex":92,"minAge":93,"maxAge":56,"enrollmentInfo":94,"targetDuration":56,"studyType":97,"phases":98,"briefSummary":101,"conditions":102,"keywords":104,"overallStatus":65,"whyStopped":56,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"PT. Prodia Stem Cell Indonesia","INDUSTRY",[8,14,20],{"label":9,"type":10,"description":11,"interventionNames":12},"NaCl 0.9%","PLACEBO_COMPARATOR","5 acute ARDS patients will be given: Standard of Care (SoC) + IV placebo (NaCl 0.9%) on the 2nd, 5th, 8th day + nasal drop 2 mL (growth medium) on the 1st, 4th, 7th day.",[13],"Other: Control (NaCl 0.9%)",{"label":15,"type":16,"description":17,"interventionNames":18},"Umbilical Cord Mesenchymal Stem Cell (UC-MSC)","EXPERIMENTAL","5 acute ARDS patients will be given: Standard of Care (SoC) + IV 10 million kg\u002Fbody weight UC-MSC on the 2nd, 5th, 8th day + nasal drop 2 mL (growth medium) on the 1st, 4th, 7th day.",[19],"Biological: UC-MSC",{"label":21,"type":16,"description":22,"interventionNames":23},"Mesenchymal Stem Cell (UC-MSC) + Secretome","5 acute ARDS patients will be given: Standard of Care (SoC) + IV 10 million kg\u002Fbody weight UC-MSC on the 2nd, 5th, 8th day + nasal drop 2 mL of Secretome on the 1st, 4th, 7th day.",[24],"Biological: UC-MSC and Secretome",[26,33,40],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"OTHER","Control (NaCl 0.9%)","Standard of Care (SoC) + IV placebo (NaCl 0.9%) on the 2nd, 5th, 8th day + nasal drop 2 mL (growth medium) on the 1st, 4th, 7th day.",[9],[32],"Standard of Care (SoC)",{"type":34,"name":35,"description":36,"armGroupLabels":37,"otherNames":38},"BIOLOGICAL","UC-MSC","Standard of Care (SoC) + IV 10 million kg\u002Fbody weight UC-MSC on the 2nd, 5th, 8th day + nasal drop 2 mL (growth medium) on the 1st, 4th, 7th day.",[15],[39],"Umbilical Cord- Mesenchymal Stem Cell (UC-MSC)",{"type":34,"name":41,"description":42,"armGroupLabels":43,"otherNames":44},"UC-MSC and Secretome","Standard of Care (SoC) + IV 10 million kg\u002Fbody weight UC-MSC on the 2nd, 5th, 8th day + nasal drop 2 mL of Secretome on the 1st, 4th, 7th day.",[21],[45],"Umbilical Cord- Mesenchymal Stem Cell (UC-MSCS) and Secretome",[47],{"name":48,"affiliation":49,"role":50},"Rima Haifa, B.Sc","Prodia StemCell Indonesia","STUDY_CHAIR",[52,58],{"name":53,"role":54,"phone":55,"phoneExt":56,"email":57},"Dewiyana Andari Kusmana","CONTACT","+6281290885529",null,"dewiyana.ku@gmail.com",{"name":59,"role":54,"phone":60,"phoneExt":56,"email":61},"Cynthia R Retna Sartika, Dr","+62811155048","c.sartika@gmail.com",[63],{"facility":64,"status":65,"city":66,"state":67,"zip":68,"country":69,"countryCode":70,"cosmosGeoPoint":71,"geoPoint":76,"contacts":77},"RSPAD Gatot Soebroto","RECRUITING","Jakarta Pusat","DKI Jakarta","10410","Indonesia","ID",{"type":72,"coordinates":73},"Point",[74,75],106.8223,-6.1818,{"lat":75,"lon":74},[78],{"name":79,"role":54,"phone":56,"phoneExt":56,"email":56},"dr. Dewiyana Andari Kusmana, SpP",{"type":81,"investigatorFullName":56,"investigatorTitle":56,"investigatorAffiliation":56,"oldNameTitle":56,"oldOrganization":56},"SPONSOR",[83],{"name":84,"class":27},"Rumah Sakit Pusat Angkatan Darat Gatot Soebroto","100626762","phase-1-mesenchymal-stem-cells-mscs-and-conditioned-medium-mesenchymal-stem-cells-as-adjuvant-therapy-for-sepsis-100626762",false,"NCT07439848","Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis","A Randomized, Double-Blind, Controlled Trial Evaluating the Potential of Mesenchymal Stem Cells and Their Secretome as Adjuvant Therapy to Reduce Length of Hospital Stay and Mortality in Patients With Sepsis Due to Pneumonia","Inclusion Criteria:\n\n* Male or female at least 40 years old when the Informed Consent Form (ICF) is signed by the family, as evidenced by an identity card.\n* Patients with severe ARDS according to Berlin criteria\n* Families are willing to participate in clinical trial procedures including not participating in other clinical trials for the duration of participation.\n\nExclusion Criteria:\n\n* A pregnant woman is proven by a pregnancy test.\n* The results of the SGOT or SGPT examination increased \\> 5 times the upper limit of the normal laboratory value in the hospital.\n* Estimated glomerular filtration rate (eGFR) \\\u003C 30 ml\u002Fmin, including patients undergoing routine hemodialysis.\n* Having more than 2 of the following co-morbidities; hypertension, diabetes, chronic heart disease, chronic lung disease, COPD, asthma, tuberculosis, cancer, chronic kidney disease, immunosuppressive disease, HIV.\n* The results of the lipid profile are far above normal (what is the cut off number?). Normal cholesterol levels for women aged 20 years and over are 125-200 mg\u002FdL with LDL below 100 mg\u002FdL and HDL above 40 mg\u002FdL. It is said to have high cholesterol when the level in the blood reaches more than 239 mg\u002FdL. Normal cholesterol levels for men aged 20 years or older are 125-200 mg\u002FdL with LDL below 100 mg\u002FdL and HDL above 40 mg\u002FdL. It is said to have high cholesterol when the level in the blood reaches more than 239 mg\u002FdL.\n* PT APTT, C Peptide","ALL","40 Years",{"count":95,"type":96},15,"ESTIMATED","INTERVENTIONAL",[99,100],"PHASE1","PHASE2","This study was conducted to determine the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) and Secretome in severe ARDS patients. The study is a randomized control trial - double blind, which has 3 arms intervention namely, Control treatment, UC-MSC treatment, and UC-MSC and Secretome treatment.",[103],"Acute Respiratory Distress Syndrome",[103,105,106],"Mesenchymal Stem Cells","Secretome","2026-02-23",{"date":109,"type":110},"2026-02-27","ACTUAL",{"date":112,"type":110},"2023-12-25",{"date":114,"type":96},"2026-12",{"name":5,"class":6},1]